Calling All Derms! Chronic Spontaneous Urticaria Is For You!
At the 2024 ODAC Dermatology, Aesthetic & Surgical Conference, we were lucky to learn about the management of chronic spontaneous urticaria (CSU) from the renowned researcher and clinician, Dr. Adam J. Friedman, Professor and Chair of Dermatology at The George Washington University School of Medicine and Health Sciences. CSU can be a frustrating, exhausting condition for patients to endure, wi …
At the 2024 ODAC Dermatology, Aesthetic & Surgical Conference, we were lucky to learn about the management of chronic spontaneous urticaria (CSU) from the renowned researcher and clinician, Dr. Adam J. Friedman, Professor and Chair of Dermatology at The George Washington University School of Medicine and Health Sciences. CSU can be a frustrating, exhausting condition for patients to endure, wi … Continue reading "Calling All Derms! Chronic Spontaneous Urticaria Is For You!"
Derm In-Review, one of the top dermatology board review prep courses, is now going on the road. The Dermatology In-Review Live Board Review Workshop is a new, in-person event to help dermatology residents prepare for the board exam.
In the past four months, residents in the Miami and New Orleans areas have attended the workshops, which were inspired by the Krazy Kodachrome sessions held at the … 
Mainstream medical dermatology is changing, and it’s about time, says Dr. R. Rox Anderson, professor at Harvard Medical School and director of the Wellman Center for Photomedicine at Massachusetts General Hospital. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Anderson about the future of product innovation. Hear what Dr. Anderson … 
Ciclopirox is the only hydroxypyridone antifungal agent with a unique mechanism of action differentiating it from other antimycotic agents. Unlike the azole-antifungals which block the sterol synthesis in the fungal cell membrane, ciclopirox functions by chelating cations resulting in the degradation of fungal cells, as well as proposed anti-inflammatory properties. It is available in a variety of … 
Tranexamic acid is one of the latest therapies for treating melasma, and one that’s most commonly prescribed for women. An editorial published in the April issue of the Journal of Drugs in Dermatology encourages dermatology clinicians to also consider the effect melasma has on men and to utilize tranexamic acid as a treatment option.
I interviewed the authors, dermatologist and Mohs surgeon A …